基于分类组学的子痫前期病因研究进展
Research Progress on Etiology of Preeclampsia Based on Taxonomy
DOI: 10.12677/acm.2024.1461820, PDF,   
作者: 陆 芳, 黄 勇:同济大学附属上海市第四人民医院妇产科,上海
关键词: 子痫前期基因组学转录组学蛋白质代谢微生物中医药Preeclampsia Genomics Transcriptomics Protein Metabolism Microorganism Traditional Chinese Medicine
摘要: 子痫前期是孕产妇死亡的首要原因之一,病因复杂并且累及多个系统。基因组学研究提示子痫前期具有遗传基因易感性,DNA甲基化失调可能导致子宫螺旋动脉侵袭缺乏。转录组学研究提示miRNA调节血管生成途径从而导致子痫前期发病。蛋白质组学重新将子痫前期分为“胎盘”、“母体抗胎儿排斥反应型”、“细胞外基质相关”、“代谢”四个亚类。代谢组学讨论了子痫前期患者氨基酸、脂肪酸代谢变化的潜在影响。微生物组学揭示了肠道、阴道微生物菌群诱发妊娠期高血压的理论机制。而中西医结合研究也从传统中医理论中探寻病机,以更好地寻找子痫前期的病因。
Abstract: Preeclampsia is one of the leading causes of maternal death. The etiology is complex and involves multiple systems. Genomics studies suggest that preeclampsia has genetic susceptibility, and DNA methylation disorders may lead to a lack of uterine spiral artery invasion. Transcriptome studies suggest that miRNAs regulate the angiogenesis pathway leading to the pathogenesis of preeclampsia. Proteomics re-divided preeclampsia into four subcategories: “placenta”, “maternal anti-fetal rejection”, “extracellular matrix-related”, and “metabolism”. Metabolomics discussed the potential effects of changes in amino acid and fatty acid metabolism in patients with preeclampsia. Microbiome reveals the theoretical mechanism of intestinal and vaginal microbial flora inducing gestational hypertension. The study of integrated traditional Chinese and Western medicine also explores the pathogenesis from the theory of traditional Chinese medicine to better find the cause of preeclampsia.
文章引用:陆芳, 黄勇. 基于分类组学的子痫前期病因研究进展[J]. 临床医学进展, 2024, 14(6): 637-642. https://doi.org/10.12677/acm.2024.1461820

参考文献

[1] Burton, G.J., Redman, C.W., Roberts, J.M. and Moffett, A. (2019) Pre-Eclampsia: Pathophysiology and Clinical Implications. BMJ, 366, L2381. [Google Scholar] [CrossRef] [PubMed]
[2] Cruz, J.d.O., Conceição, I.M.C.A., Tosatti, J.A.G., Gomes, K.B. and Luizon, M.R. (2020) Global DNA Methylation in Placental Tissues from Pregnant with Preeclampsia: A Systematic Review and Pathway Analysis. Placenta, 101, 97-107. [Google Scholar] [CrossRef] [PubMed]
[3] Parada-Niño, L., Castillo-León, L.F. and Morel, A. (2022) Preeclampsia, Natural History, Genes, and Mirnas Associated with the Syndrome. Journal of Pregnancy, 2022, Article ID 3851225. [Google Scholar] [CrossRef] [PubMed]
[4] Steinthorsdottir, V., McGinnis, R., Williams, N.O., Stefansdottir, L., Thorleifsson, G., Shooter, S., et al. (2020) Genetic Predisposition to Hypertension Is Associated with Preeclampsia in European and Central Asian Women. Nature Communications, 11, Article No. 5976. [Google Scholar] [CrossRef] [PubMed]
[5] Mtshali, Z., Moodley, J. and Naicker, T. (2020) An Insight into the Angiogenic and Lymphatic Interplay in Pre-Eclampsia Comorbid with HIV Infection. Current Hypertension Reports, 22, Article No. 35. [Google Scholar] [CrossRef] [PubMed]
[6] Mütze, S., Rudnik-Schöneborn, S., Zerres, K. and Rath, W. (2008) Genes and the Preeclampsia Syndrome. Journal of Perinatal Medicine, 36, 38-58. [Google Scholar] [CrossRef] [PubMed]
[7] Zhang, Q., Wang, Z., Cheng, X. and Wu, H. (2021) Lncrna DANCR Promotes the Migration an Invasion and of Trophoblast Cells through Microrna-214-5p in Preeclampsia. Bioengineered, 12, 9424-9434. [Google Scholar] [CrossRef] [PubMed]
[8] Fan, W., Zhou, W., Yan, Q., Peng, Y., Wang, H., Kong, C., et al. (2022) Upregulation of METTL14 Contributes to Trophoblast Dysfunction by Elevating Foxo3a Expression in an M6a-Dependent Manner. Placenta, 124, 18-27. [Google Scholar] [CrossRef] [PubMed]
[9] Kamrani, A., Alipourfard, I., Ahmadi-Khiavi, H., Yousefi, M., Rostamzadeh, D., Izadi, M., et al. (2019) The Role of Epigenetic Changes in Preeclampsia. BioFactors, 45, 712-724. [Google Scholar] [CrossRef] [PubMed]
[10] Wang, R., Wan, S.K., Wang, X.Q., Huang, W.X., Dai, M.Y., Mi, C.Y. and Hui, Z. (2022) Regulatory Roles of Non-Coding RNAs and m6A Modification in Trophoblast Functions and the Occurrence of Its Related Adverse Pregnancy Outcomes. Critical Reviews in Toxicology, 52, 681-713.
[11] Ali, A., Hadlich, F., Abbas, M.W., Iqbal, M.A., Tesfaye, D., Bouma, G.J., Winger, Q.A. and Ponsuksili, S. (2021) MicroRNA-mRNA Net-works in Pregnancy Complications: A Comprehensive Downstream Analysis of Potential Biomarkers. International Journal of Molecular Sciences, 22, Article 2313.
[12] Nguyen, T.P.H., Patrick, C.J., Parry, L.J. and Familari, M. (2019) Using Proteomics to Advance the Search for Potential Biomarkers for Preeclampsia: A Systematic Review and Meta-Analysis. PLOS ONE, 14, e0214671. [Google Scholar] [CrossRef] [PubMed]
[13] Rana, S., Lemoine, E., Granger, J.P. and Karumanchi, S.A. (2019) Preeclampsia. Circulation Research, 124, 1094-1112. [Google Scholar] [CrossRef] [PubMed]
[14] Avendanha, R.A., Campos, G.F.C., Branco, B.C., Ishii, N.C., Gomes, L.H.N., de Castro, A.J., et al. (2024) Potential Urinary Biomarkers in Preeclampsia: A Narrative Review. Molecular Biology Reports, 51, Article No. 172. [Google Scholar] [CrossRef] [PubMed]
[15] Hurrell, A., Webster, L., Sparkes, J., Battersby, C., Brockbank, A., Clark, K., Duhig, K.E., Gill, C., Green, M., Hunter, R.M., Seed, P.T., Vowles, Z., Myers, J., Shennan, A.H., Chappell, L.C. and PARROT-2 Trial Group (2024) Repeat Placental Growth Factor-Based Testing in Women with Suspected Preterm Pre-Eclampsia (PARROT-2): A Multicentre, Parallel-Group, Superiority, Randomised Controlled Trial. Lancet, 403, 619-631.
[16] Eddy, A.C., Bidwell III, G.L. and George, E.M. (2018) Pro-Angiogenic Therapeutics for Preeclampsia. Biology of Sex Differences, 9, Article No. 36.
[17] Than, N.G., Romero, R., Posta, M., Györffy, D., Szalai, G., Rossi, S.W., et al. (2024) Classification of Preeclampsia According to Molecular Clusters with the Goal of Achieving Personalized Prevention. Journal of Reproductive Immunology, 161, Article ID: 104172. [Google Scholar] [CrossRef] [PubMed]
[18] Yao, M., Xiao, Y., Yang, Z., Ge, W., Liang, F., Teng, H., et al. (2022) Identification of Biomarkers for Preeclampsia Based on Metabolomics. Clinical Epidemiology, 14, 337-360. [Google Scholar] [CrossRef] [PubMed]
[19] Ortiz-Cerda, T., Mosso, C., Alcudia, A., Vázquez-Román, V. and González-Ortiz, M. (2023) Pathophysiology of Preeclampsia and L-Arginine/L-Citrulline Supplementation as a Potential Strategy to Improve Birth Outcomes. Advances in Experimental Medicine and Biology, 1428, 127-148.
[20] Mayrink, J., Leite, D.F., Nobrega, G.M., Costa, M.L. and Cecatti, J.G. (2022) Prediction of Pregnancy-Related Hypertensive Disorders Using Metabolomics: A Systematic Review. BMJ Open, 12, e054697. [Google Scholar] [CrossRef] [PubMed]
[21] Poniedziałek-Czajkowska, E. and Mierzyński, R. (2021) Could Vitamin D Be Effective in Prevention of Preeclampsia? Nutrients, 13, Article 3854. [Google Scholar] [CrossRef] [PubMed]
[22] Avery, E.G., Bartolomaeus, H., Maifeld, A., Marko, L., Wiig, H., Wilck, N., et al. (2021) The Gut Microbiome in Hypertension. Circulation Research, 128, 934-950. [Google Scholar] [CrossRef] [PubMed]
[23] Ahmadian, E., Rahbar Saadat, Y., Hosseiniyan Khatibi, S.M., Nariman-Saleh-Fam, Z., Bastami, M., Zununi Vahed, F., et al. (2020) Pre-eclampsia: Microbiota Possibly Playing a Role. Pharmacological Research, 155, Article ID: 104692. [Google Scholar] [CrossRef] [PubMed]
[24] Chen, X., Li, P., Liu, M., Zheng, H., He, Y., Chen, M., et al. (2020) Gut Dysbiosis Induces the Development of Pre-Eclampsia through Bacterial Translocation. Gut, 69, 513-522. [Google Scholar] [CrossRef] [PubMed]
[25] 栗婵. 复方丹参注射液联合硝苯地平治疗早发型子痫前期的疗效观察[J]. 实用中西医结合临床, 2023, 23(14): 68-71. [Google Scholar] [CrossRef
[26] 李姝, 仝玉珠, 李平平. 镇肝熄风汤对子痫前期患者钙镁离子水平、细胞毒性因子-血管内皮功能的影响[J]. 世界中西医结合杂志, 2023, 18(4): 728-732, 736. [Google Scholar] [CrossRef